COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors

Bibliographic Details
Title: COVID-19 vaccine uptake among young adults: Influence of asthma and sociodemographic factors
Authors: Maria Ödling, PhD, Niklas Andersson, MSc, Sandra Ekström, PhD, Niclas Roxhed, PhD, Jochen M. Schwenk, PhD, Sophia Björkander, PhD, Anna Bergström, PhD, Erik Melén, MD, PhD, Inger Kull, PhD
Source: Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 2, Pp 100231- (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: Asthma control, allergic disease, birth cohort, comorbidity, population based, SARS-CoV-2, Immunologic diseases. Allergy, RC581-607
More Details: Background: Asthma was initially described as a risk factor for severe coronavirus disease 2019 (COVID-19), but the uptake of COVID-19 vaccine among young adults with asthma is not well studied. Objective: The aims were to assess COVID-19 vaccine uptake among young adults in general and to explore potential determinants including sociodemographic factors and asthma. Methods: Participants from the population-based birth cohort BAMSE (Barn/Child, Allergy, Milieu, Stockholm, Epidemiology) were included: 4,064 in the study population, 3,064 in a follow-up at age 24 years, and 2,049 in a COVID-19 follow-up (mean age, 26.5 years). Asthma and asthma-associated characteristics were assessed through questionnaires and clinical data. Data on all COVID-19 vaccines registered between January 1, 2021, and February 15, 2023, were extracted from the National Vaccination Register. Results: In the study population (n = 4,064), 53.9% had ≥3 COVID-19 vaccine doses registered. In the 24-year follow-up population (n = 3,064), vaccine uptake differed in relation to education (P < .001). Among the participants with university/college education, 65.7% had an uptake of ≥3 doses of vaccine, compared to 54.1% among the participants with elementary school/high school education. Participants with asthma had decreased odds of receiving ≥3 doses (adjusted odds ratio = 0.62; 95% confidence interval, 0.41-0.92) and ≥2 compared to peers without asthma. Those with uncontrolled disease also had decreased odds of receiving ≥3 doses (adjusted odds ratio = 0.30; 95% confidence interval, 0.13-0.66) and ≥2 compared to participants with controlled asthma. Conclusions: COVID-19 vaccine uptake among young adults is lower in individuals from households with lower socioeconomic status and among those with asthma, including uncontrolled asthma.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2772-8293
Relation: http://www.sciencedirect.com/science/article/pii/S2772829324000274; https://doaj.org/toc/2772-8293
DOI: 10.1016/j.jacig.2024.100231
Access URL: https://doaj.org/article/fa705b4fe32a4d9e9acab5b57ff3adf9
Accession Number: edsdoj.fa705b4fe32a4d9e9acab5b57ff3adf9
Database: Directory of Open Access Journals
More Details
ISSN:27728293
DOI:10.1016/j.jacig.2024.100231
Published in:Journal of Allergy and Clinical Immunology: Global
Language:English